Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dobutamine does not influence inflammatory pathways during human endotoxemia.

Lucienne C Lemaire1, Martijn D de Kruif, Ida A Giebelen

  • 1Department of Anesthesiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Critical Care Medicine
|March 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence in diagnostics and medical decision making.

European journal of internal medicine·2026
Same author

Response to the comment by Gando on the updated definition and scoring of disseminated intravascular coagulation.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Laboratory and Medicine 2.1: Care for What You Wish for.

International journal of laboratory hematology·2026
Same author

Two years and counting: a prospective cohort study on the scope and severity of post-COVID symptoms across diverse patient groups in the Netherlands-insights from the CORFU study.

BMJ open·2025
Same author

International journal of obstetric anesthesia·2025
Same author

Regional analgesia techniques for postoperative pain after breast cancer surgery: a network meta-analysis.

The Cochrane database of systematic reviews·2025
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Attracting Emergency Medicine Graduates to Surgical Critical Care Training Programs.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Beyond a Snapshot: Tracking Family Prognostic Expectations in the ICU.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure: Beware of Potential Confounders.

Critical care medicine·2026
See all related articles

Dobutamine, a synthetic catecholamine, did not alter inflammatory or coagulant responses in healthy volunteers given endotoxin. This study found no immunomodulatory effects of dobutamine during human endotoxemia.

Area of Science:

  • Immunology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Catecholamines possess anti-inflammatory and anticoagulant properties.
  • Dobutamine is a synthetic catecholamine commonly used for septic myocardial dysfunction.
  • Its potential immunomodulatory effects in endotoxemia require investigation.

Purpose of the Study:

  • To determine if continuous dobutamine infusion impacts inflammatory and coagulant pathways in healthy volunteers during an endotoxin challenge.
  • To assess the immunomodulatory effects of dobutamine in a human endotoxemia model.

Main Methods:

  • A prospective, open-label study involving 16 healthy male volunteers.
  • Participants received either dobutamine (10 microg/kg/min) or saline infusion.
  • Endotoxin (Escherichia coli) was administered via bolus injection 1 hour after infusion initiation.

Related Experiment Videos

Main Results:

  • Dobutamine increased mean arterial blood pressure and heart rate compared to saline.
  • Endotoxin triggered systemic cytokine release, endothelial activation, coagulation activation, and fibrinolysis changes.
  • Dobutamine infusion did not significantly alter any of the endotoxin-induced inflammatory or coagulant responses.

Conclusions:

  • Dobutamine, at a clinically relevant dose, does not modulate the inflammatory or coagulant pathways during human endotoxemia.
  • These findings suggest dobutamine does not exert significant immunomodulatory effects in this context.